220 related articles for article (PubMed ID: 34733840)
21. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
[TBL] [Abstract][Full Text] [Related]
22. Integrating single-cell and bulk expression data to identify and analyze cancer prognosis-related genes.
Bao S; Fan Y; Mei Y; Gao J
Heliyon; 2024 Feb; 10(4):e25640. PubMed ID: 38379985
[TBL] [Abstract][Full Text] [Related]
23. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
[TBL] [Abstract][Full Text] [Related]
24. High Expression of ERK-related RASGRF2 predicts Poor prognosis in patients with Stomach Adenocarcinoma and correlates with M2 macrophage.
Du Y; Wang Z; Wan W
J Cancer; 2021; 12(23):7177-7189. PubMed ID: 34729119
[No Abstract] [Full Text] [Related]
25. Identification of mitochondrial respiratory chain signature for predicting prognosis and immunotherapy response in stomach adenocarcinoma.
Yang J; Jin F; Li H; Shen Y; Shi W; Wang L; Zhong L; Wu G; Wu Q; Li Y
Cancer Cell Int; 2023 Apr; 23(1):69. PubMed ID: 37062830
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of a novel molecular classification incorporating oxidative stress and metabolism-related genes for stomach adenocarcinoma in the framework of predictive, preventive, and personalized medicine.
Dong Y; Yuan Q; Ren J; Li H; Guo H; Guan H; Jiang X; Qi B; Li R
Front Endocrinol (Lausanne); 2023; 14():1090906. PubMed ID: 36860371
[TBL] [Abstract][Full Text] [Related]
27. GPX3-Mediated Oxidative Stress Affects Pyrimidine Metabolism Levels in Stomach Adenocarcinoma via the AMPK/mTOR Pathway.
Zhang Y; Yang Y; Kuang S; Zhang Y; Qin H; Xie J
Int J Clin Pract; 2024; 2024():6875417. PubMed ID: 38322113
[TBL] [Abstract][Full Text] [Related]
28. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
Guo L; Liu D
Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a prognostic model based on a single-cell RNA-seq in Wilms tumor in children.
He TQ; Zhao YW; Ning F; Liu Y; Tu L; He J
J Investig Med; 2023 Mar; 71(3):173-182. PubMed ID: 36718830
[TBL] [Abstract][Full Text] [Related]
30. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma.
Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P
Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547
[TBL] [Abstract][Full Text] [Related]
31. Protein Phosphatase 1 Regulatory Subunit 3: A Prognostic Biomarker in Stomach Adenocarcinoma.
Zhu YZ; Liao XW; Yin W; Wei HM
Int J Gen Med; 2022; 15():1131-1146. PubMed ID: 35153505
[TBL] [Abstract][Full Text] [Related]
32. Construction of a circular RNA-microRNA-messengerRNA regulatory network in stomach adenocarcinoma.
Liu Q; Zhang W; Wu Z; Liu H; Hu H; Shi H; Li S; Zhang X
J Cell Biochem; 2020 Feb; 121(2):1317-1331. PubMed ID: 31486138
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of Adenosine-to-Inosine RNA editing-based subtypes and novel risk score for the prognosis and drug sensitivity in stomach adenocarcinoma.
Pan J; Gu X; Luo J; Qian X; Gao Q; Li T; Ye L; Li C
Front Cell Dev Biol; 2022; 10():1073688. PubMed ID: 36531956
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ITGB1-DT expression delays the growth and migration of stomach adenocarcinoma and improves the prognosis of cancer patients using the bioinformatics and cell model analysis.
Jiang N; Guo Q; Luo Q
J Gastrointest Oncol; 2022 Apr; 13(2):615-629. PubMed ID: 35557569
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma.
Pi Y; Zhan Y; Song J; Jin X; Chen J
J Gastrointest Oncol; 2022 Aug; 13(4):1589-1604. PubMed ID: 36092347
[TBL] [Abstract][Full Text] [Related]
37. Analysis of expression profile of miRNA in stomach adenocarcinoma.
Huo Q
J BUON; 2017; 22(5):1154-1159. PubMed ID: 29135097
[TBL] [Abstract][Full Text] [Related]
38. Identification of distinct tumor cell patterns with single-cell RNA sequencing integrating primary lung adenocarcinoma and brain metastasis tumor.
Wang X; Zhang D; Guan X; Ma S; Zhou W; Peng J; Yuan L; Wang Y; Jin S; Xu Q; Li D; Wu S; Jia G; Zhang C; Jia W
Transl Lung Cancer Res; 2023 Mar; 12(3):547-565. PubMed ID: 37057123
[TBL] [Abstract][Full Text] [Related]
39. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast Activation Protein-Alpha is a Prognostic Biomarker Associated With Ferroptosis in Stomach Adenocarcinoma.
Lyu Z; Li Y; Zhu D; Wu S; Hu F; Zhang Y; Li Y; Hou T
Front Cell Dev Biol; 2022; 10():859999. PubMed ID: 35359436
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]